戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s, in which it elicited high titers of DEN-2 virus-neutralizing antibody.
2  a complex of the HAstV capsid protein and a virus-neutralizing antibody.
3  (HIV-1(DH12)) developed an extremely potent virus-neutralizing antibody.
4 in a delayed production of high affinity and virus neutralizing antibodies.
5 RS((R)) MLV strain, A2MC2-P90 elicits higher virus neutralizing antibodies.
6 e serum samples were negative for anti-Nipah virus neutralizing antibodies.
7 l epitopes necessary to elicit high-titered, virus-neutralizing antibodies.
8 unogenic form that elicits highly functional virus-neutralizing antibodies.
9  conformational epitopes important to elicit virus-neutralizing antibodies.
10 tein B that is able to induce high titers of virus-neutralizing antibodies.
11 another through nanotubes in the presence of virus-neutralizing antibodies.
12  structures within gB that are recognized by virus-neutralizing antibodies.
13 uction in the CNS prior to the appearance of virus-neutralizing antibodies.
14 HCMV is a major antigen for the induction of virus-neutralizing antibodies.
15  antibody responses as well as for anti-AD-5 virus-neutralizing antibodies.
16 eading to the production of higher levels of virus-neutralizing antibodies.
17 ith host cell membranes and is recognized by virus-neutralizing antibodies.
18 nterferon response and delayed production of virus-neutralizing antibodies.
19 olonies and much higher prevalence of rabies virus-neutralizing antibodies.
20 f virion-specific immunoglobulin G (IgG) and virus-neutralizing antibodies.
21  of the INF-gamma gene failed to produce any virus-neutralizing antibodies.
22 ss switch from immunoglobulin M (IgM) to IgG virus-neutralizing antibodies.
23                                              Virus-neutralizing antibodies (Abs) coat MMTV virions se
24 moral responses, including the production of virus-neutralizing antibodies (Abs) directed at viral en
25 s the contribution of cellular responses and virus-neutralizing antibodies (Abs) to the control of re
26 munization of the monkeys with L(EV)-induced virus-neutralizing antibodies against EBO-Z caused a sli
27 ciation with zoonosis, the prevalence of the virus-neutralizing antibody against three recovirus sero
28 tween measured levels of serotypes of dengue virus neutralizing antibody and clinical outcomes sugges
29 he presence of GLA-SE induced high titers of virus-neutralizing antibodies and conferred complete lun
30 tection correlated with the presence of both virus-neutralizing antibodies and primed CTL in the immu
31 pment of subunit vaccines are able to induce virus-neutralizing antibodies and protective efficacy in
32  with DeltaG-89.6P-RVG developed SHIV(89.6P) virus-neutralizing antibodies and SHIV(89.6P)-specific c
33 s (glycans), some of which are recognized by virus-neutralizing antibodies and some of which protect
34 , with serum antibody titers to both measles virus (neutralizing antibody) and HPIV3 (hemagglutinatio
35 es virus-specific binding antibodies, rabies virus neutralizing antibodies, and rabies virus antigens
36 N-003 elicited increases in antigen binding, virus neutralizing antibody, and T-cell responses.
37 e Q508 escape mutation common to a number of virus-neutralizing antibodies, and therefore provides fu
38 oded proteins, and a significant fraction of virus neutralizing antibodies are directed at gB.
39                                        Mumps virus-neutralizing antibodies are believed to be the mos
40 We have shown that during natural infection, virus-neutralizing antibodies are principally directed a
41 ted pigs are delayed onset and low levels of virus neutralizing antibodies, as well as weak cell-medi
42                              The presence of virus-neutralizing antibodies at the time of infection w
43 logical activities, such as the induction of virus-neutralizing antibody, cell-virus fusion, and cell
44             Furthermore, passive transfer of virus-neutralizing antibodies completely compensated for
45 irus vaccine, which generates high levels of virus neutralizing antibodies, confers reduced virus loa
46 ecipients remained asymptomatic, with rabies virus neutralizing antibodies detected in their serum af
47 emic H1N1 virus elicited a boost in titer of virus-neutralizing antibodies directed against the hemag
48 a donor with broadly cross-reactive, primary virus-neutralizing antibodies (donor of reference serum,
49 ters and induced very high levels of measles virus neutralizing antibodies (>1:8,000) that are well i
50                    Although gp120 can elicit virus-neutralizing antibodies, HIV eludes the immune sys
51  FeLV-specific effector CTLs appeared before virus neutralizing antibodies in cats that recovered fro
52 sally, induced surface glycoprotein-specific virus neutralizing antibodies in serum and immunoglobuli
53 ded various results on its ability to induce virus-neutralizing antibodies in animal models and human
54              Both antigens elicited specific virus-neutralizing antibodies in immunized mice.
55 raised substantial levels of antipeptide and virus-neutralizing antibodies in sera and of peptide-spe
56 dministered intranasally, induced F-specific virus-neutralizing antibodies in serum and immunoglobuli
57 novirus 5 (AdHu5), is the high prevalence of virus-neutralizing antibodies in the human population.
58 rus-resistant mice control the pathogen with virus-neutralizing antibodies independently of commensal
59 LnJ H2-Ob allele supported the production of virus-neutralizing antibodies independently of the class
60 a broad spectrum of responses which includes virus neutralizing antibodies is a desirable goal for le
61                                We isolated a virus-neutralizing antibody lineage that targeted an env
62 immunized mice developed high-titer vaccinia virus-neutralizing antibodies (mean PRNT50 = 1:3,760).
63 nfection stimulates higher levels of measles-virus-neutralizing antibodies (mnAbs) than does vaccinat
64 redominantly tier 1 and/or autologous tier 2 virus neutralizing antibody (NAb) responses, as well as
65 activated HRV vaccine can be protective, and virus-neutralizing antibodies (nAb) correlated with prot
66                                    Influenza virus neutralizing antibodies (NAbs) are promising proph
67                              However, potent virus neutralizing antibodies (NAbs) can develop during
68 ability of the engineered antigens to elicit virus-neutralizing antibodies (NAbs).
69 ope glycoprotein (Env) that is the target of virus-neutralizing antibodies on the surfaces of virions
70 ed Brucella abortus induces the secretion of virus-neutralizing antibodies, predominantly of the immu
71 infection is complex and is known to include virus-neutralizing antibody production against surface g
72 function of these cells is the production of virus-neutralizing antibodies rather than priming or rea
73 ion at a low multiplicity with wild-type FIX virus, neutralizing antibody reduced the accumulation of
74 is associated with the induction of a robust virus-neutralizing antibody response and clearance of th
75 These data indicated that gM/gN can elicit a virus-neutralizing antibody response in humans infected
76                             Furthermore, the virus-neutralizing antibody response in wild-type mice c
77  mechanism to control the development of the virus-neutralizing antibody response required for recove
78 -deficient mice correlated with a more rapid virus-neutralizing antibody response than was observed i
79 amma-deficient mice developed an accelerated virus-neutralizing antibody response, they did not class
80 e cells failed to elicit either viremia or a virus-neutralizing antibody response.
81  previous study, the vaccine elicited strong virus neutralizing antibody responses in sheep and was D
82            hMPV-infected cotton rats mounted virus-neutralizing antibody responses and were partially
83                                              Virus-neutralizing antibody responses did not explain wh
84 rtance of inducing both T cell responses and virus-neutralizing antibody responses for effective retr
85 ls and in some cases was also independent of virus-neutralizing antibody responses.
86 ers of subtype cross-reactive antibodies and virus-neutralizing antibodies specific for the immunizin
87 ed I/LnJ mice are capable of producing IgG2a virus-neutralizing antibodies, sustain this response thr
88 esenting two rabies virus epitopes stimulate virus neutralizing antibody synthesis in immunized mice.
89 junction induced about 400-fold more measles virus-neutralizing antibody than did the rPIV3 with the
90 assays that can be used to measure influenza virus-neutralizing antibodies that are not detected in t
91 accination, which correlated positively with virus neutralizing antibody titer, the ability to resist
92                    The vaccine elicited high virus neutralizing antibody titers and conferred complet
93 strong correlation was observed between high virus neutralizing antibody titers and protection follow
94  prompt and potent stimulation of protective virus neutralizing antibody titers, which are produced i
95 fluid, total anti-IAV IgG and IgA titers and virus-neutralizing antibody titers but not hemagglutinin
96                                 Serum rabies virus-neutralizing antibody titers sufficed to protect n
97 h nodes and the peripheral blood, and higher virus-neutralizing antibody titers than immunization wit
98 sues of all VLP-inoculated groups, but serum virus-neutralizing antibody titers were not significantl
99 ific immunoglobulin G antibody responses and virus-neutralizing antibody titers.
100 oglobulins nor could they maintain long-term virus-neutralizing antibody titers.
101 nfluenza pandemic possess highly functional, virus-neutralizing antibodies to this uniquely virulent
102 imal is recognized, prompt administration of virus-neutralizing antibodies, together with active immu
103 with wt RABV did not activate DCs, stimulate virus neutralizing antibodies (VNA), or protect recipien
104 ene-deleted RV vaccine induced 4-fold higher virus-neutralizing antibody (VNA) levels in rhesus macaq
105 verexpression of CXCL13 resulted in enhanced virus-neutralizing antibody (VNA) production and protect
106                                 Furthermore, virus-neutralizing antibody (VNA) titers were significan
107 10 p.i.) production of significant levels of virus-neutralizing antibody (VNA).
108 cation-deficient RABV-based vaccine produced virus neutralizing antibodies (VNAs) within 3 days of va
109 nized with LBNSE-CXCL13 produced more rabies virus-neutralizing antibodies (VNAs) and developed bette
110 l deficiency, we show that B cells secreting virus-neutralizing antibodies (VNAs) are induced via T c
111  long-lived PCs, it also generated prolonged virus-neutralizing antibodies (VNAs), resulting in bette
112                Similarly, influenza-specific virus-neutralizing antibody was generated and maintained
113 generated by each of the three vaccines, but virus-neutralizing antibodies were detected only in mice
114 genes and functional IFN-gamma genes because virus-neutralizing antibodies were still generated, cons
115 at recombinant trimers may be able to elicit virus-neutralizing antibodies when delivered as immunoge
116 epitopes primed for more rapid production of virus-neutralizing antibody which appeared to limit viru
117 aled that LNPs induced high titers of Dengue virus neutralizing antibodies, with or without co-admini
118                               Interestingly, virus-neutralizing antibodies worked synergistically wit

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top